AG˹ٷ

STOCK TITAN

[Form 4] Sabra Healthcare REIT, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Insider sale recorded by Michael J. Foster at Sabra Health Care REIT (SBRA). On 08/19/2025 the filing reports a disposition of 750 shares of the issuer's common stock under transaction code G, with $0 price reported for that line. After the reported transaction, the reporting person is shown as beneficially owning 72,317 shares directly and 42,411.745 shares indirectly through a 401(k) plan. The filing notes that the total direct holdings include 6,815 unvested stock units and 44,982 vested stock units with deferred payment; each stock unit equals one share. The form is signed by Michael Costa as attorney-in-fact on 08/19/2025.

Operazione di insider sale registrata da Michael J. Foster presso Sabra Health Care REIT (SBRA). In data 19/08/2025 la comunicazione riporta una cessione di 750 azioni dell'azione ordinaria dell'emittente con codice di transazione G, con prezzo indicato pari a $0 per quella linea. Dopo l'operazione segnalata, la persona che comunica risulta detenere beneficiariamente 72.317 azioni direttamente e 42.411,745 azioni indirettamente tramite un piano 401(k). La comunicazione precisa che le partecipazioni dirette totali includono 6.815 unità azionarie non maturate e 44.982 unità azionarie maturate con pagamento differito; ogni unità azionaria corrisponde a una azione. Il modulo è firmato da Michael Costa in qualità di procuratore il 19/08/2025.

Venta de insider registrada por Michael J. Foster en Sabra Health Care REIT (SBRA). El 19/08/2025 la presentación informa una disposición de 750 acciones de las acciones ordinarias del emisor bajo el código de transacción G, con precio reportado de $0 en esa línea. Tras la transacción reportada, la persona informante figura como titular beneficiario de 72.317 acciones directamente y de 42.411,745 acciones de forma indirecta a través de un plan 401(k). La presentación indica que las tenencias directas totales incluyen 6.815 unidades de acciones no devengadas y 44.982 unidades de acciones devengadas con pago diferido; cada unidad de acción equivale a una acción. El formulario está firmado por Michael Costa como apoderado el 19/08/2025.

Michael J. Foster가 Sabra Health Care REIT(SBRA)에서 신고� 내부� 매각. 2025-08-19� 제출서에� 거래코드 G� 발행사의 보통� 750� 처분� 보고되어 있으� 해당 항목� 가격은 $0으로 기재되어 있습니다. 보고� 거래 이후, 신고인은 직접적으� 72,317주를, 401(k) 플랜� 통해 간접적으� 42,411.745주를 실질적으� 보유� 것으� 표시되어 있습니다. 제출서에� 직접 보유 총액� 6,815� 미확� 주식 단위와 44,982� 확정� 지연지� 주식 단위가 포함되어 있다� 명시되어 있으�, � 주식 단위� � 주에 해당합니�. 해당 양식은 2025-08-19� 대리인 자격으로 Michael Costa가 서명했습니다.

Vente d'initié enregistrée par Michael J. Foster chez Sabra Health Care REIT (SBRA). Le 19/08/2025, le dépôt signale une cession de 750 actions ordinaires de l'émetteur sous le code de transaction G, avec un prix déclaré de 0 $ pour cette ligne. Après la transaction signalée, la personne déclarante apparaît comme détenant bénéficiairement 72 317 actions directement et 42 411,745 actions indirectement via un plan 401(k). Le dépôt précise que les avoirs directs totaux comprennent 6 815 unités d'actions non acquises et 44 982 unités d'actions acquises avec paiement différé ; chaque unité d'action équivaut à une action. Le formulaire est signé par Michael Costa en tant que mandataire le 19/08/2025.

Insider-Verkauf verzeichnet von Michael J. Foster bei Sabra Health Care REIT (SBRA). In der Einreichung vom 19.08.2025 wird eine Veräußerung von 750 Aktien der Stammaktien des Emittenten unter dem Transaktionscode G gemeldet; für diese Zeile ist ein Preis von $0 angegeben. Nach der gemeldeten Transaktion wird die meldende Person als wirtschaftlicher Eigentümer von 72.317 Aktien direkt und 42.411,745 Aktien indirekt über einen 401(k)-Plan ausgewiesen. Die Einreichung weist darauf hin, dass die gesamten Direktbestände 6.815 nicht unverfallbare Aktienanteile und 44.982 unverfallbare, mit aufgeschobener Auszahlung versehene Aktienanteile enthalten; jede Aktienanteilseinheit entspricht einer Aktie. Das Formular ist am 19.08.2025 von Michael Costa als Bevollmächtigter unterzeichnet.

Positive
  • Form discloses both direct (72,317) and indirect (42,411.745) beneficial ownership, providing transparency
  • Notes clearly state composition of direct holdings: 6,815 unvested units and 44,982 vested but deferred units
Negative
  • None.

Insights

TL;DR: A small, routine insider disposition leaves substantial remaining insider holdings; transaction appears immaterial to company capital structure.

The Form 4 shows a reported sale of 750 shares (code G) completed on 08/19/2025, after which the reporting person holds 72,317 shares directly and 42,411.745 indirectly via a 401(k). The footnote clarifies composition of direct holdings including 6,815 unvested units and 44,982 vested but deferred units. Given the scale of remaining holdings, this single disposition is small in absolute terms and does not change the insider's overall stake materially.

TL;DR: Disclosure appears complete for the reported transaction; documentation includes deferred and unvested unit detail and an attorney-in-fact signature.

The filing provides the necessary breakdown of beneficial ownership between direct and indirect holdings and discloses the nature of stock units (vested, deferred, unvested). The signature block shows filing by an attorney-in-fact, which is permitted when properly authorized. There is no indication in the document of any material governance event or change in control.

Operazione di insider sale registrata da Michael J. Foster presso Sabra Health Care REIT (SBRA). In data 19/08/2025 la comunicazione riporta una cessione di 750 azioni dell'azione ordinaria dell'emittente con codice di transazione G, con prezzo indicato pari a $0 per quella linea. Dopo l'operazione segnalata, la persona che comunica risulta detenere beneficiariamente 72.317 azioni direttamente e 42.411,745 azioni indirettamente tramite un piano 401(k). La comunicazione precisa che le partecipazioni dirette totali includono 6.815 unità azionarie non maturate e 44.982 unità azionarie maturate con pagamento differito; ogni unità azionaria corrisponde a una azione. Il modulo è firmato da Michael Costa in qualità di procuratore il 19/08/2025.

Venta de insider registrada por Michael J. Foster en Sabra Health Care REIT (SBRA). El 19/08/2025 la presentación informa una disposición de 750 acciones de las acciones ordinarias del emisor bajo el código de transacción G, con precio reportado de $0 en esa línea. Tras la transacción reportada, la persona informante figura como titular beneficiario de 72.317 acciones directamente y de 42.411,745 acciones de forma indirecta a través de un plan 401(k). La presentación indica que las tenencias directas totales incluyen 6.815 unidades de acciones no devengadas y 44.982 unidades de acciones devengadas con pago diferido; cada unidad de acción equivale a una acción. El formulario está firmado por Michael Costa como apoderado el 19/08/2025.

Michael J. Foster가 Sabra Health Care REIT(SBRA)에서 신고� 내부� 매각. 2025-08-19� 제출서에� 거래코드 G� 발행사의 보통� 750� 처분� 보고되어 있으� 해당 항목� 가격은 $0으로 기재되어 있습니다. 보고� 거래 이후, 신고인은 직접적으� 72,317주를, 401(k) 플랜� 통해 간접적으� 42,411.745주를 실질적으� 보유� 것으� 표시되어 있습니다. 제출서에� 직접 보유 총액� 6,815� 미확� 주식 단위와 44,982� 확정� 지연지� 주식 단위가 포함되어 있다� 명시되어 있으�, � 주식 단위� � 주에 해당합니�. 해당 양식은 2025-08-19� 대리인 자격으로 Michael Costa가 서명했습니다.

Vente d'initié enregistrée par Michael J. Foster chez Sabra Health Care REIT (SBRA). Le 19/08/2025, le dépôt signale une cession de 750 actions ordinaires de l'émetteur sous le code de transaction G, avec un prix déclaré de 0 $ pour cette ligne. Après la transaction signalée, la personne déclarante apparaît comme détenant bénéficiairement 72 317 actions directement et 42 411,745 actions indirectement via un plan 401(k). Le dépôt précise que les avoirs directs totaux comprennent 6 815 unités d'actions non acquises et 44 982 unités d'actions acquises avec paiement différé ; chaque unité d'action équivaut à une action. Le formulaire est signé par Michael Costa en tant que mandataire le 19/08/2025.

Insider-Verkauf verzeichnet von Michael J. Foster bei Sabra Health Care REIT (SBRA). In der Einreichung vom 19.08.2025 wird eine Veräußerung von 750 Aktien der Stammaktien des Emittenten unter dem Transaktionscode G gemeldet; für diese Zeile ist ein Preis von $0 angegeben. Nach der gemeldeten Transaktion wird die meldende Person als wirtschaftlicher Eigentümer von 72.317 Aktien direkt und 42.411,745 Aktien indirekt über einen 401(k)-Plan ausgewiesen. Die Einreichung weist darauf hin, dass die gesamten Direktbestände 6.815 nicht unverfallbare Aktienanteile und 44.982 unverfallbare, mit aufgeschobener Auszahlung versehene Aktienanteile enthalten; jede Aktienanteilseinheit entspricht einer Aktie. Das Formular ist am 19.08.2025 von Michael Costa als Bevollmächtigter unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
FOSTER MICHAEL J

(Last) (First) (Middle)
C/O SABRA HEALTH CARE REIT, INC.
1781 FLIGHT WAY

(Street)
TUSTIN CA 92782

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Sabra Health Care REIT, Inc. [ SBRA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/19/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/19/2025 G 750 D $0 72,317(1) D
Common Stock 42,411.745 I 401(k) Plan
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Includes 6,815 unvested stock units and 44,982 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.
Remarks:
/s/ Michael Costa, as Attorney-in-Fact 08/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction was reported on the Form 4 for SBRA?

The filing reports a disposition of 750 shares of Sabra Health Care REIT common stock on 08/19/2025 (transaction code G).

How many shares does the reporting person own after the transaction?

After the reported transaction, the reporting person beneficially owns 72,317 shares directly and 42,411.745 shares indirectly via a 401(k) plan.

What do the stock unit footnotes reveal in the Form 4?

The footnote states the direct holdings include 6,815 unvested stock units and 44,982 stock units that have vested but payment has been deferred, with each unit representing one share.

Who signed the Form 4 and when?

The form is signed by Michael Costa, as Attorney-in-Fact on 08/19/2025.
Sabra Health Care Reit Inc

NASDAQ:SBRA

SBRA Rankings

SBRA Latest News

SBRA Latest SEC Filings

SBRA Stock Data

4.47B
236.75M
1.27%
101.54%
8.01%
REIT - Healthcare Facilities
AG˹ٷ Estate Investment Trusts
United States
TUSTIN